David Charles Link - 31 Dec 2021 Form 5 Insider Report for QSAM Biosciences, Inc. (QSAM)

Role: Director
Signature: /s/ Charles Link Jr.
Issuer symbol: QSAM
Transactions as of: 31 Dec 2021
Transactions value $: $0
Form type: 5
Filing time: 15 Feb 2022, 05:11:47 UTC
Previous filing: 22 Oct 2021
Next filing: 09 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	QSAM	Series E-1 Preferred Stock	Other		-850	-100%		0	06 Dec 2021	Direct	F1
transaction	QSAM	Common Stock	Other		+2.88M			2.88M	06 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	QSAM	Options to buy common	Award	$0	+55K		$0.00	55K	24 Aug 2021	Common Stock	55K	$0.36	Direct	F2
transaction	QSAM	Series E-1 Preferred Shares	Award	$0	+850		$0.00^*	0	15 Feb 2021	Common Stock	850K	$0.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to reclassification exempt under Rule 16b-7, each share of Series E-1 Preferred Stock was reclassified into and exchanged for shares of Common Stock of the Issuer under the terms of Exchange Agreement and Plan of Reorganization as filed with the SEC.
F2	The option vests semi-annually in two equal installments beginning on 02/24/2022.
F3	Series E-1 Preferred Stock was convertible at any time at the discretion of the holder at a ratio of 1000 shares of Common Stock per Series E-1 Preferred Stock.